This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Magellan (MGLN) Q1 Earnings Top on Lower Medical Utilization
by Zacks Equity Research
Magellan Health's (MGLN) Q1 earnings benefit from higher profit owing to lower utilization of elective procedures.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Molina Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Molina Healthcare
Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q1 results reflect high expenses and low net income.
Molina (MOH) Lags Q1 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of -0.33% and 2.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Molina Healthcare (MOH) This Earnings Season?
by Zacks Equity Research
Molina Healthcare (MOH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.
Will Membership Growth Drive Cigna's (CI) Earnings in Q1?
by Zacks Equity Research
Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.
Molina Healthcare's (MOH) Q1 Earnings: What's in Store?
by Zacks Equity Research
Molina Healthcare's (MOH) first-quarter results are likely to reflect lower membership, partly offset by better revenues.
What's in the Cards for Anthem's (ANTM) Earnings in Q1?
by Zacks Equity Research
Anthem's (ANTM) Q1 earnings results are likely to reflect higher revenues, backed by its Government and Commercial & Specialty businesses.
Humana (HUM) Gears up for Earnings in Q1: What to Expect
by Zacks Equity Research
Humana's (HUM) Q1 earnings results are likely to reflect growth in revenues, which in turn, are expected to have been driven by its Medicaid and Medicare businesses.
Molina (MOH) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Molina (MOH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Centene's (CNC) Earnings in Q1?
by Zacks Equity Research
Centene's (CNC) Q1 results are likely to reflect escalating expenses, partially offset by higher revenues.
HMO Industry: Bullish Near-Term Outlook Despite Coronavirus Impact
by Sapna Bagaria
Health Insurers are likely to gain from higher demand for its products and services from senior citizens and the rising incidence of illness, partially offset by the COVID-19-led fallout.
HCA Healthcare (HCA) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 results are likely to reflect weak volumes from the coronavirus effect.
Molina Healthcare Gains on Sanders' Exit From Presidential Race
by Zacks Equity Research
Molina Healthcare (MOH) gains from Bernie Sanders' withdrawal from the presidential campaign.
UnitedHeath (UNH) Beats on Q1 Earnings, Dodges Coronavirus Curse
by Zacks Equity Research
UnitedHealth's (UNH) Q1 earnings benefit from higher contribution at both its segments, escaping the fallout from the coronavirus-led crisis.
Molina (MOH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Molina (MOH) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Anthem, Humana, Molina Healthcare and Magellan Health
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Molina Healthcare, Cigna, UnitedHealth, Anthem and Humana
7 Health Insurers Poised to Beat Earnings Estimates in Q1
by Zacks Equity Research
Health insurers are likely to gain from a solid revenue base, attributable to higher premiums across Medicare, Medicaid plans.
Centene Soars 47.8% in Six Months: Will the Rally Continue?
by Zacks Equity Research
Centene's (CNC) strategic initiatives and higher membership might aid its revenues to perk up its share price in turn.
Is Molina Healthcare (MOH) Stock a Solid Choice Right Now?
by Zacks Equity Research
Molina Healthcare (MOH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Sanders Gives Health Insurers a Boost: Spotlight on 5 Stocks
by Tirthankar Chakraborty
Sanders' policies haven't been positive for health insurance stocks. He has favored Medicare-For-All and intended to abolish private insurance, which had cast a shadow on health insurance companies for months.